Special Diabetes Program for Indians Reauthorization Act of 2023

Bill 118 HR 2547, also known as the Special Diabetes Program for Indians Reauthorization Act of 2023, is a piece of legislation that aims to reauthorize funding for the Special Diabetes Program for Indians (SDPI). The SDPI is a program that provides grants to Indian Health Service, tribal, and urban Indian health programs to prevent and treat diabetes among Native American populations.

The bill seeks to reauthorize the SDPI for an additional five years, providing $200 million in funding each year. This funding will be used to support diabetes prevention and treatment programs, as well as research initiatives aimed at improving outcomes for Native Americans with diabetes.

In addition to reauthorizing funding for the SDPI, the bill includes provisions to improve data collection and reporting on diabetes among Native American populations. It also aims to increase access to culturally appropriate diabetes care and education for Native Americans. Overall, Bill 118 HR 2547 is focused on addressing the high rates of diabetes among Native American populations and improving health outcomes for this vulnerable group. By reauthorizing funding for the SDPI and implementing additional measures to support diabetes prevention and treatment, the bill aims to make a positive impact on the health and well-being of Native Americans across the country.